Economic Burden from Health Losses Due to Foodborne Illness in the United States

被引:599
作者
Scharff, Robert L. [1 ]
机构
[1] Ohio State Univ, Columbus, OH 43210 USA
关键词
POPULATION; INFECTIONS; DISEASE;
D O I
10.4315/0362-028X.JFP-11-058
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The Centers for Disease Control and Prevention (CDC) recently revised their estimates for the annual number of foodborne illnesses; 48 million Americans suffer from domestically acquired foodborne illness associated with 31 identified pathogens and a broad category of unspecified agents. Consequently, economic studies based on the previous estimates are now obsolete. This study was conducted to provide improved and updated estimates of the cost of foodbome illness by adding a replication of the 2011 CDC model to existing cost-of-illness models. The basic cost-of-illness model includes economic estimates for medical costs, productivity losses, and illness-related mortality (based on hedonic value-of-statistical-life studies). The enhanced cost-of-illness model replaces the productivity loss estimates with a more inclusive pain, suffering, and functional disability measure based on monetized quality-adjusted life year estimates. Costs are estimated for each pathogen and a broader class of unknown pathogens. The addition of updated cost data and improvements to methodology enhanced the performance of each existing economic model. Uncertainty in these models was characterized using Monte Carlo simulations in @Risk version 5.5. With this model, the average cost per case of foodborne illness was $1,626 (90% credible interval [CI] $607 to $3,073) for the enhanced cost-of-illness model and $1,068 (90% CI, $683 to $1,646) for the basic model. The resulting aggregated annual cost of illness was $77.7 billion (90% CI. $28.6 to $144.6 billion) and $51.0 billion (90% CI. $31.2 to $76.1 billion) for the enhanced and basic models, respectively.
引用
收藏
页码:123 / 131
页数:9
相关论文
共 20 条
[1]  
Adler Matthew D, 2006, Yale J Health Policy Law Ethics, V6, P1
[2]  
[Anonymous], 2020, INTR HCUP NAT INP SA
[3]   The value of a statistical life: A meta-analysis with a mixed effects regression model [J].
Bellavance, Francois ;
Dionne, Georges ;
Lebeau, Martin .
JOURNAL OF HEALTH ECONOMICS, 2009, 28 (02) :444-464
[4]  
Bureau of Labor Statistics, 2010, CONS PRIC IND ALL UR
[5]   The Economics of Enteric Infections: Human Foodborne Disease Costs [J].
Buzby, Jean C. ;
Roberts, Tanya .
GASTROENTEROLOGY, 2009, 136 (06) :1851-1862
[6]  
Centers for Disease Control and Prevention, 2010, FOODNET SURV REP 200
[7]   QALYs versus WTP [J].
Hammitt, JK .
RISK ANALYSIS, 2002, 22 (05) :985-1001
[8]   Diminishing Willingness to Pay per Quality-Adjusted Life Year: Valuing Acute Foodborne Illness [J].
Haninger, Kevin ;
Hammitt, James K. .
RISK ANALYSIS, 2011, 31 (09) :1363-1380
[9]   The return on investment in health care: From 1980 to 2000 [J].
Luce, BR ;
Mauskopf, J ;
Sloan, FA ;
Ostermann, J ;
Paramore, LC .
VALUE IN HEALTH, 2006, 9 (03) :146-156
[10]   Self-reported health status of the general adult US population as assessed by the EQ-5D and Health Utilities Index [J].
Luo, N ;
Johnson, JA ;
Shaw, JW ;
Feeny, D ;
Coons, SJ .
MEDICAL CARE, 2005, 43 (11) :1078-1086